A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
A phase 3 trial of Cisplatin in advanced solid tumours, run by Jiangsu Simcere Pharmaceutical Co., Ltd., active and no longer recruiting.
Overview
A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions is a phase 3 interventional study registered as NCT04914598 by Jiangsu Simcere Pharmaceutical Co., Ltd., with 290 participants enrolled, started 2021-07-28 and due to reach its primary completion in 2025-02-10. Interventions recorded: ENDOSTAR，cisplatin and Placebo , cisplatin.
Similar pages
not linked directly; found by shared links- TrialA Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TreatmentSIM0270
Shares Simcere Pharmaceutical and the tag pipeline.
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialTo Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Shares Cisplatin, Metastatic cancer (cancer that has spread) and the tag pipeline.